Projected Income Statement: LANXESS AG

Forecast Balance Sheet: LANXESS AG

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 2,245 3,814 2,498 2,381 2,023 2,070 1,995 1,875
Change - 69.89% -34.5% -4.68% -15.04% 2.32% -3.62% -6.02%
Announcement Date 3/11/22 3/15/23 3/14/24 3/19/25 3/18/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: LANXESS AG

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 479 407 326 320 319 327.4 328.8 342.9
Change - -15.03% -19.9% -1.84% -0.31% 2.63% 0.43% 4.29%
Free Cash Flow (FCF) 1 -40 -248 512 188 -30 80 148.2 170.6
Change - -520% 306.45% -63.28% -115.96% 366.67% 85.19% 15.12%
Announcement Date 3/11/22 3/15/23 3/14/24 3/19/25 3/18/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: LANXESS AG

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 13.37% 11.5% 7.63% 9.64% 8.99% 8.64% 9.41% 9.99%
EBIT Margin (%) 6.62% 4.81% -0.79% 0.83% -0.48% 0.46% 1.54% 2.02%
EBT Margin (%) 4.01% 3.18% -14.1% -3.09% -8.3% -4.75% -1.68% -0.86%
Net margin (%) 3.53% 3.09% 6.6% -2.78% -10.17% -3.66% -1.45% 0.24%
FCF margin (%) -0.53% -3.07% 7.63% 2.95% -0.53% 1.38% 2.5% 2.79%
FCF / Net Income (%) -14.98% -99.2% 115.58% -106.21% 5.2% -37.59% -172.66% 1,172.16%

Profitability

        
ROA 2.75% 2.29% 4.23% 1.4% -6.61% -4.11% -2.15% -1.41%
ROE 7.9% 6.11% 9.93% -3.9% -14.28% -6.68% -3.59% -1.32%

Financial Health

        
Leverage (Debt/EBITDA) 2.22x 4.1x 4.88x 3.88x 3.97x 4.12x 3.57x 3.07x
Debt / Free cash flow -56.12x -15.38x 4.88x 12.66x -67.43x 25.88x 13.47x 10.99x

Capital Intensity

        
CAPEX / Current Assets (%) 6.34% 5.03% 4.86% 5.03% 5.62% 5.63% 5.54% 5.62%
CAPEX / EBITDA (%) 47.43% 43.76% 63.67% 52.12% 62.55% 65.22% 58.9% 56.22%
CAPEX / FCF (%) -1,197.5% -164.11% 63.67% 170.21% -1,063.33% 409.24% 221.94% 201.06%

Items per share

        
Cash flow per share 1 4.714 1.355 9.705 5.883 3.347 3.164 4.063 4.039
Change - -71.26% 616.41% -39.38% -43.11% -5.46% 28.4% -0.59%
Dividend per Share 1 1.05 1.05 0.1 0.1 0.1 0.1 0.2093 0.2845
Change - 0% -90.48% 0% 0% 0% 109.34% 35.91%
Book Value Per Share 1 43.5 51.2 52.13 53.11 40.48 38.36 38.44 36.93
Change - 17.7% 1.81% 1.89% -23.79% -5.23% 0.21% -3.92%
EPS 1 3.09 2.13 5.13 -2.05 -6.68 -2.434 -1.04 -1.098
Change - -31.07% 140.85% -139.96% -225.85% 63.56% 57.28% -5.57%
Nbr of stocks (in thousands) 86,258 86,346 86,346 86,346 86,346 86,346 86,346 86,346
Announcement Date 3/11/22 3/15/23 3/14/24 3/19/25 3/18/26 - - -
1EUR
Estimates
2026 *2027 *
P/E -6.55x -15.3x
PBR 0.42x 0.41x
EV / Sales 0.59x 0.57x
Yield 0.63% 1.31%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
15.94EUR
Average target price
17.64EUR
Spread / Average Target
+10.68%

Quarterly revenue - Rate of surprise